Unapproved New Drugs/Misbranded
Similar Posts
GDUFA Paid Facilities List
This list contains GDUFA facility payments received by the Agency. Data are extract from the User Fee System and GDUFA Facility User Fee Coversheets. The following table explains the terms used in the list:Online Controlled Substances Summits
FDA hosted its fourth summit on June 8, 2023, as an integral part of FDA’s overall efforts to protect the public, including youth, from harm associated with drugs that have abuse potential.New England Home Therapies Inc. Southborough, MA. 483 Issued 01/27/2016
Record Date 01/27/2016
FEI Number 1000120535
Firm Name New England Home Therapies Inc.
Record Type 483
State MA
Establishment Type Producer of Sterile Drug ProductsGreen Lumber Holding, LLC Issues Consumer Alert on Counterfeit Products Following FDA Findings
Costa Mesa, California August 28, 2025 – Green Lumber Holding, LLC (“Green Lumber”) is alerting consumers that counterfeit products misrepresented as genuine Green Lumber have been identified and may pose health risks.Glenmark Pharmaceuticals Limited – 708270 – 07/11/2025
CGMP/Finished Pharmaceuticals/AdulteratedPromotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers
The guidance addresses questions that manufacturers, packers, distributors, and their representatives (firms) may have when developing FDA-regulated promotional labeling and advertisements for prescription reference products, biosimilar products, and interchangeable biosimilar products.
